During the course of aging both activation and degenerative changes are fou
nd in the human hypothalamus. Degeneration may start around middle-age in s
ome neurotransmitter- or neuromodulator-containing neurons. For instance, a
decreased number of vasoactive intestinal polypeptide (VIP) neurons was ob
served in the suprachiasmatic nucleus (SCN) of middle-aged males. The norma
l circadian fluctuations seen in the number of vasopressin (AVP) neurons in
the SCN of young subjects diminished in subjects older than 50 years. More
over, a sharp decline in cell number was found in the sexually dimorphic nu
cleus (SDN) after 50 years in males. On the other hand, many hypothalamic s
ystems remain perfectly intact during aging like the oxytocin (OXT) neurons
in the paraventricular nucleus (PVN). The AVP neurons in the PVN are activ
ated during aging as appears from their increasing cell number. Also the co
rticotrophin-releasing hormone (CRH) neurons of the PVN are activated in th
e course of aging, as indicated by their increased number and their increas
ed AVP coexpression. Part of the infundibular nucleus, the subventricular n
ucleus, contains hypertrophic neurokinin B neurons in postmenopausal women.
It can be concluded that a multitude of changes in the various hypothalami
c nuclei may be the biological basis for many functional changes in aging,
i.e., both endocrine and central alterations, and that only a minority of t
he possible human hypothalamic changes have so far been studied. (C) 1999 W
iley-Liss, Inc.